Alcon AG vs ARK Fintech Innovation ETF — how do they compare? Alcon AG trades at $72.42 (market cap $36.44B), while ARK Fintech Innovation ETF trades at $42.86. The key difference: Alcon AG pays a 0.48% dividend while ARK Fintech Innovation ETF pays none. Which is the better fit depends on your goals.
| ALC | ARKF | |
|---|---|---|
Market Cap | $36.44B | — |
Sector | Health | Sector/Thematic |
52-Week High | $90.12 | $58.82 |
52-Week Low | $62.02 | $36.14 |
Enterprise Value | $40.28B | — |
Dividend Yield | 0.48% | — |
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.
Read more on ARKF →